05:25 PM EDT • Endpoints News • Catalent’s Covid-19 vaccine manufacturing site hit with Form 483 over foreign objects in vials and other QC issues
05:11 PM EDT • Investor's Business Daily • Biotech Stocks Notch A Blazing Path In 2022 — Why The Good Times Aren't Over
11:06 AM EDT • BioSpace • BrainStorm’s ALS Drug Heads to the FDA with Correction to Phase III Analyses
10:40 AM EDT • Nature • How does monkeypox spread? What scientists know
10:29 AM EDT • STAT • What scientists know — and don’t know — about how monkeypox spreads
09:45 AM EDT • The Jerusalem Post | JPost.com • COVID-19: Pfizer CEO Albert Bourla tests positive, has mild symptoms
05:42 PM EDT • Reuters • EU in talks for common purchase of vaccine, antiviral against monkeypox
05:36 PM EDT • STAT • Health officials scramble to raise monkeypox awareness ahead of Pride Month
05:18 PM EDT • CDC • Monkeypox
05:12 PM EDT • AP - The Associated Press • WHO: Nearly 200 cases of monkeypox in more than 20 countries
11:17 AM EDT • Fox News • Pfizer, BioNTech will ask FDA to authorize COVID booster for healthy kids ages 5-11
11:09 AM EDT • pfizer • Pfizer and BioNTech Announce Data Demonstrating High Immune Response Following a Booster Dose of their COVID-19 Vaccine in Children 5 Through 11 Years of Age
05:05 PM EDT • Endpoints News • Doug Melton to reunite with his Semma collaborators at Vertex to develop 'curative cell therapies'
12:34 PM EDT • poandpo • New Zealand reports 21,616 new COVID-19 community cases
12:28 PM EDT • NBC • How Hong Kong went from 'zero-Covid' to the world's highest death rate
12:24 PM EDT • New York Times • China’s Covid Lockdowns Set to Further Disrupt Global Supply Chains
12:22 PM EDT • AP - The Associated Press • German health minister still sees ‘critical’ COVID situation
12:11 PM EDT • NBC • As COVID cases rise in the UK, what to expect in the US
12:00 PM EST • European Medicines Agency (EMA) • Spikevax (previously COVID-19 Vaccine Moderna): Pending EC decision
11:52 AM EST • yahoo • Moderna is ‘clawing back market share’ from Pfizer, analyst says
11:48 AM EST • YouTube • Moderna CEO Stéphane Bancel: We're likely moving into an endemic setting
11:39 AM EST • Moderna, Inc. • Moderna Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Updates
12:11 AM EST • BBC • Covid: How new drugs are finally taming the virus
09:09 AM EST • MarketWatch • Regeneron earnings boosted by $804 million in sales of COVID antibody treatment
09:05 AM EST • YouTube • Regeneron says single dose of Covid antibody cocktail provides long-term protection
09:00 AM EST • Reuters • Regeneron's COVID antibody drug shows protection for up to 8 months
12:08 PM EDT • New York Times • Covid Live Updates: Pfizer Says Its Antiviral Pill Is Highly Effective
12:06 PM EDT • CNBC • Pfizer board member Gottlieb says the Covid pandemic could be over in the U.S. by January
01:48 PM EDT • MIT Technology Review • Is Ginkgo’s synthetic-biology story worth $15 billion?
01:46 PM EDT • New York Times • Biology Starts to Get a Technological Makeover
01:44 PM EDT • yahoo • GINKGO BIOWORKS INVESTIGATION: Block & Leviton Is Investigating Ginkgo Bioworks Holdings For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm
01:37 PM EDT • markets.businessinsider.com • Ginkgo Bioworks plunges 24% after short-seller calls it a 'Frankenstein mash-up of the worst frauds'
05:39 PM EDT • CNN • How chili peppers helped Nobel Prize winners understand how we feel heat
05:34 PM EDT • New York Times • Nobel Prize Awarded for Research About Temperature and Touch
11:16 AM EDT • markets.businessinsider.com • Moderna and BioNTech plummet more than 15% following news of Merck's COVID-19 antiviral pill
10:13 AM EDT • CNBC • Merck says its new Covid pill reduces the risk of hospitalization, death by half for some patients
04:04 PM EDT • BioPharma Dive • After long wait, Editas reveals first data for CRISPR gene editing treatment
03:20 PM EDT • Investor's Business Daily • EDIT Stock Firestorm Continues After CRISPR Gene-Editing Drug Underwhelms
03:18 PM EDT • Genetic Engineering & Biotechnology News • Editas Early Data for CRISPR Therapy EDIT-101 Shows Efficacy “Signals” in Two Patients
09:07 AM EDT • NPR - National Public Radio • Pfizer And BioNTech Say Vaccine Trial For Kids Shows Its Safe And Effective
09:01 AM EDT • CNBC • Pfizer says its Covid vaccine is safe and generates robust immune response in kids ages 5 to 11
03:22 PM EDT • CNBC • Two senior FDA vaccine regulators are stepping down
03:13 PM EDT • Endpoints News • BREAKING: In a major blow to vaccine efforts, senior FDA leaders stepping down
01:53 PM EDT • YouTube • How Moderna And Pfizer-BioNTech Developed Vaccines In Record Time
04:47 PM EDT • MarketWatch • Lilly, Boehringer Ingelheim: Jardiance Shows 21% Relative Risk Reduction in Diastolic Heart Failure
04:40 PM EDT • Vantage • ESC 2021 – Jardiance blows Entresto out of the water
04:37 PM EDT • FiercePharma • ESC 2021: Eli Lilly, Boehringer's Jardiance racks up data for 2nd nod in crowded heart failure field
04:23 PM EDT • New England Journal of Medicine (NEJM) • Empagliflozin and Major Renal Outcomes in Heart Failure
03:44 PM EDT • New York Times • Covid-19 Updates: F.D.A. Grants Full Approval to Pfizer-BioNTech Covid Vaccine
03:40 PM EDT • CNBC • FDA grants full approval to Pfizer-BioNTech’s Covid shot, clearing path to more vaccine mandates